Former Israeli Prime Minister Ehud Barak will chair the Israeli medical marijuana company InterCure, according to the firm, which made the announcement on Wednesday.

Barak served as defense minister and then prime minister in the early 2000s. He has remained in the public spotlight since leaving politics, usually criticizing current government policies.

InterCure said that Barak will head its global growth initiative. In a statement, the company said Barak’s “stature” will be helpful for the company’s development.

Barak will work 40 monthly hours for $10,000 per month. He will also be eligible for stock options, according to the company.

InterCure, publicly traded in Israel, is expected to change its name to Canndoc Pharma.

Just before you scroll on...

Israel is at war. JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you. The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support? Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today

Already a member? Log in to stop seeing this